ACADSB and nonpapillary renal cell carcinoma: Yue Wu et al. demonstrated that mitochondrial gene signatures, including ACADSB, could accurately predict OS, and ACADSB had good diagnostic and prognostic abilities in ccRCC (Liu et al., 2021; Wu et al., 2021).